Related by context. All words. (Click for frequent words.) 69 mg/m2 IV 68 #mg/m# [002] 66 mg/m2/day 65 mg m² 65 mcg kg 65 administered subcutaneously 64 mg orally 64 dosed orally 63 #mg/m# [001] 63 q#h 63 mg/m2 63 mg QD 63 4mg/kg 62 ribavirin RBV 62 subcutaneous doses 62 8mg/kg 62 subcutaneous enoxaparin 62 ug kg 62 #mg/day [002] 62 subcutaneous injections 61 subcutaneous dose 61 subcutaneously administered 61 abacavir lamivudine 61 alfa 2a 61 mg qd 61 #mg QD [002] 61 mcg doses 61 mL kg 61 mg TID 61 plus ribavirin 61 mg administered orally 61 atazanavir ritonavir 61 Q2W 60 mg kg dose 60 #mg/kg [002] 60 ritonavir boosted 60 saline placebo 60 Peg IFN 60 CIMZIA TM 60 fluticasone salmeterol 60 intramuscularly 60 lopinavir r 60 peginterferon alpha 2a 60 mcg dose 60 timepoints 60 μg kg 60 Flu Cy 60 mcg BID 60 mg/m2 administered 60 pegylated interferon alfa 2a 60 continuous intravenous infusion 60 injected subcutaneously 60 #.#mg/kg [002] 59 tipranavir r 59 PEG IFN 59 μg mL 59 estramustine 59 5mg/kg 59 certolizumab 59 salmeterol fluticasone 59 microgram kg 59 LPV r 59 subcutaneous infusion 59 Kinoid 59 hours postdose 59 lispro 59 q8h 59 interferon alfa 2b 59 intermittent dosing 59 hour bronchodilation 59 mg/# hr 59 peginterferon alfa 2a #KD 59 rFSH 59 dose cohort 59 #mg QD [001] 58 intravenous bolus injection 58 administered intradermally 58 rizatriptan 58 subcutaneous dosing 58 piperacillin tazobactam 58 GnRH agonist 58 QD dosing 58 epoetin alpha 58 virologic breakthrough 58 bolus dose 58 mg dosed twice 58 mg RDEA# 58 mg kg intravenously 58 mg ustekinumab 58 insulin detemir 58 mcg QD 58 mg kg 58 LANTUS R 58 μg dose 58 ml kg 58 #mg BID [003] 58 interferon alfa 2a 58 AUC0 58 ascending doses 58 mg BID 58 ALT normalization 58 peginterferon alfa 2b 58 VELCADE melphalan 58 ribavirin therapy 58 relapsed MM 57 mg/m2 dose 57 IV bolus 57 #mg/day [001] 57 Copegus ribavirin 57 oral prednisone 57 Cmax 57 mCi 57 PREZISTA ritonavir 57 mg kg hr 57 daily subcutaneous injections 57 CHOP chemotherapy 57 insulin glulisine 57 #mg BID [001] 57 weekly subcutaneous injections 57 μg 57 pegIFN 57 dosing interval 57 non splenectomized 57 EUFLEXXA R 57 Aptivus ® 57 administered intramuscularly 57 Pegasys plus Copegus 57 mg q8h 57 APTIVUS r 57 detemir 57 peginterferon alfa 57 LEXIVA r 57 mg dosed 57 TDF FTC 57 inhaled iloprost 57 #μg [002] 57 subcutaneous SC 57 flutamide 57 isoproterenol 57 severe neutropenia 57 ascending dose 57 maximal dose 57 inhalations twice 57 budesonide pMDI 56 Pharmacokinetics PK 56 min -1 56 adalimumab Humira 56 alpha 2a 56 inhaled fluticasone 56 #ug [002] 56 fluorouracil leucovorin 56 mg d 56 intravenous IV infusion 56 PegIFN 56 mcg mL 56 kBq kg 56 uM 56 3mg/kg 56 elevated transaminases 56 nab paclitaxel 56 peg interferon 56 plus methotrexate 56 #/#.# mcg 56 aPTT 56 #mg doses [001] 56 antiandrogen 56 R entecavir 56 tinzaparin 56 μmol L 56 mg simvastatin 56 RNA copies mL 56 Leucovorin 56 ibandronate 56 intravenous vancomycin 56 intravenous infusion 56 QTcF 56 #mg dose [001] 56 detectable HCV RNA 56 nicardipine 56 TAXOTERE R 56 divalproex sodium 56 otamixaban 56 kg -1 56 cGy 56 infused intravenously 56 amoxicillin clavulanate 56 mg m 56 pegylated interferon alpha 56 ALT elevations 56 mcg 55 adriamycin 55 bronchodilation 55 nevirapine NVP 55 OADs 55 PRADAXA #mg 55 #mg q8h 55 ribavirin USP 55 fumarate 55 Known hypersensitivity 55 MBq 55 PREZISTA r 55 cefazolin 55 plus COPEGUS 55 oral rivaroxaban 55 potent CYP#A# inhibitors 55 intravenous heparin 55 cisplatin gemcitabine 55 Gy fractions 55 BARACLUDE ® 55 mg iv peramivir 55 HBeAg seroconversion 55 Insulin PH# 55 bisoprolol 55 ceftazidime 55 Pegylated Interferon 55 administered intranasally 55 nadolol 55 pyrazinamide 55 timepoint 55 #.#mg/dL 55 intravenous dose 55 mg/# hours 55 mg dose 55 intradermal injections 55 dosing intervals 55 FOLFIRI alone 55 dose regimens 55 FFNS 55 bolus injection 55 neurologic progression 55 zonisamide SR 55 CR CRu 55 comparator arm 55 1mg 55 noninferior 55 anagrelide 55 postdose 55 nevirapine Viramune 55 ara C 55 ritonavir boosted atazanavir 55 doxorubicin cyclophosphamide 55 trimethoprim sulfamethoxazole 55 adjunctive placebo 55 clodronate 55 formoterol fumarate 55 methylprednisolone 55 intramuscular IM injection 55 beta2 agonist 55 mcg kg min 55 GHRH 55 INFERGEN 55 docetaxel chemotherapy 55 μg ml 55 zoledronate 55 TPV r 55 injected intramuscularly 55 intraperitoneal injection 55 8mg 55 #μg [001] 55 NovoLog ® Mix 55 pamidronate 55 genotypic resistance 55 mg eq 55 intravenous bolus 55 ritonavir boosted protease inhibitor 55 mitoxantrone 55 progression TTP 55 microg 55 ORENCIA ® 55 Pegasys peginterferon alfa 2a 55 cis retinoic acid 55 undetectable HCV RNA 55 3mg 55 atazanavir Reyataz 55 chlorambucil 55 APIDRA R 55 mitoxantrone plus 55 oral levofloxacin 55 fluticasone furoate 55 corticosteroid therapy 55 adefovir dipivoxil 54 insulin degludec 54 carboplatin AUC 54 q# 54 DLTs 54 leuprorelin 54 Capesaris 54 plasma uric acid 54 pegylated liposomal doxorubicin 54 kilogram mg kg 54 FOLFOX6 54 PULMICORT RESPULES 54 epoetin beta 54 #.#g/day 54 Peginterferon 54 dalteparin 54 antiretroviral naive 54 tolterodine ER 54 biphasic insulin aspart 54 taxane resistant 54 lispro alone 54 #mg dose [002] 54 caspofungin 54 amprenavir 54 Arikace 54 idarubicin 54 FUSILEV enhances 54 milligram doses 54 acromegalic patients 54 induction regimen 54 #mg doses [002] 54 lopinavir r arm 54 6 mercaptopurine 54 systemic immunosuppressive 54 mg subcutaneous injection 54 inecalcitol 54 nadroparin 54 CorVue TM 54 oral allopurinol 54 darunavir ritonavir 54 intravenous dosing 54 dosing 54 mg subcutaneously 54 serum cortisol 54 ispinesib administered 54 weekly intravenous infusions 54 peg IFN 54 PegIFN RBV 54 systemic corticosteroid 54 paclitaxel Taxol R 54 #mg #mg #mg [003] 54 thalidomide dexamethasone 54 generation purine nucleoside 54 aspartate aminotransferase 54 Engerix B 54 subcutaneously injected 54 corticosteroid dose 54 ethambutol 54 interferon ribavirin 54 chemoradiation therapy 54 achieved ACR# 54 ìg 54 FOLPI 54 activated partial thromboplastin 54 Vidaza azacitidine 54 tazobactam 54 heavily pretreated patients 54 μg d 54 doxorubicin docetaxel 54 pharmacokinetics PK 54 sub maximal 54 coadministration 54 mg/# h 54 mg clopidogrel 54 6mg 54 PSA nadir 54 #.#/#.# mm Hg [003] 54 lenalidomide dexamethasone 54 deferoxamine 54 Hep B vaccine 54 low dose cytarabine 54 palivizumab 54 5FU 54 follitropin beta 54 Telithromycin 54 1mg 2mg 54 rHuEPO 54 peginterferon alfa 2a 54 epoetin alfa 54 Elitek 53 atazanavir sulfate 53 corrected QT interval 53 mCi kg 53 dose titration 53 % CI #.#-#.# [003] 53 goserelin 53 clotrimazole 53 β blocker 53 oral clodronate 53 cyclophosphamide vincristine 53 #mg/#mg 53 p = NS 53 undetectable virus HCV 53 subcutaneously 53 Sanofi Pasteur Fluzone 53 HBeAg positive patients 53 Pegasys ® 53 REYATAZ r arm 53 rabeprazole 53 dosage regimens 53 epirubicin cyclophosphamide 53 maximal doses 53 vecuronium 53 intravenous doses 53 nalbuphine 53 administered concomitantly 53 pharmacokinetic parameters 53 dacarbazine 53 CIMZIA R 53 hMG 53 MAS XR 53 receiving VICTRELIS 53 BENICAR 53 rapid virologic response 53 amphotericin B 53 #mg [003] 53 naïve HCV 53 azilsartan medoxomil 53 hypomagnesemia 53 pyrimidine nucleoside analog 53 terbutaline 53 desvenlafaxine succinate 53 intravenously administered 53 remifentanil 53 ® lenalidomide 53 dosing cohorts 53 mcg albinterferon alfa 2b 53 octreotide LAR 53 Perforomist Inhalation Solution 53 insulin lispro 53 concentration Cmax 53 BENICAR HCT 53 injectable investigational 53 melphalan prednisone 53 receiving highly emetogenic 53 cytarabine daunorubicin 53 efavirenz EFV 53 mg p = 53 prucalopride 53 refractory NSCLC 53 telaprevir dosed 53 CCyR 53 ganciclovir 53 #ug [001] 53 oral dosing 53 statin monotherapy 53 carboplatin paclitaxel 53 partial remissions 53 alefacept 53 inhaled corticosteroid ICS 53 treatment naive genotype 53 dosage regimen 53 mRCC 53 pegylated interferon alfa 53 dasatinib Sprycel ® 53 adjuvant tamoxifen 53 cyclophosphamide methotrexate 53 transdermal estradiol 53 reteplase 53 nmol 53 pegylated alpha interferon 53 Abrupt discontinuation 53 biologic DMARD 53 Vagifem 53 IU ml 53 mg doses 53 Pegylated interferon 53 intravenous morphine 53 protease inhibitor PI 53 CR nPR 53 μg doses 53 Omacetaxine mepesuccinate 53 azathioprine 53 antidepressant trazodone 53 DMARD therapy 53 terfenadine 53 PEGylated anti 53 corifollitropin alfa 53 Pemetrexed 53 administered orally 53 recombinant follicle stimulating 53 Toxicities 53 FIRMAGON 53 nephrotoxic 53 Lucentis ranibizumab Genentech 53 forodesine 53 receiving INTRON 53 biochemical relapse 52 NovoMix ® 52 QAB# indacaterol 52 intratympanic 52 oral methylnaltrexone 52 COPEGUS 52 suppressive therapy 52 hemoptysis 52 mg tid 52 controlled analgesia PCA 52 β blockers 52 piroxicam 52 SVR# 52 maximally tolerated dose 52 ropivacaine 52 virologic failure 52 aminotransferase elevations greater 52 pg mL 52 virologically 52 intramuscular injection 52 #mg ATC 52 #mg ritonavir 52 intra muscular 52 intranasal formulation 52 anthracyclines taxanes 52 patients evaluable 52 viral kinetics 52 CrCl 52 IFN α 52 subcutaneous insulin 52 oral antidiabetic medication 52 IELT 52 SELZENTRY 52 mycophenolate 52 clinically meaningful improvement 52 Lamictal XR 52 Primary endpoints 52 urate lowering therapy 52 PEG interferon 52 QT QTc 52 irinotecan chemotherapy 52 ‰ ¥ 52 tirofiban 52 docetaxel Taxotere 52 boosted protease inhibitor 52 Peginterferon Alfa 2a 52 leukocyte count 52 virological response 52 2mg 52 microgram mcg 52 dexamethasone Decadron 52 moderate renal impairment 52 ACTEMRA TM 52 Secondary endpoints include 52 nelfinavir 52 intravenous antibiotic 52 Acetate Rectal Suppositories 52 oral alendronate 52 febrile neutropenia 52 mometasone furoate 52 rifapentine 52 cetuximab Erbitux ® 52 lenalidomide Revlimid R 52 FOLFOX4 alone 52 griseofulvin 52 intravitreal injection 52 GPIIb IIIa inhibitors 52 ß blockers 52 Indacaterol 52 ertapenem 52 FOLFIRI 52 rhGH 52 rt PA 52 DAPT 52 fluvastatin 52 dose cyclophosphamide 52 Febrile neutropenia 52 Durezol 52 acetazolamide 52 posttransplant 52 darunavir r 52 pimecrolimus cream 52 clinically meaningful improvements 52 voriconazole 52 TMC# r 52 pruritus itching 52 REYATAZ R 52 preterm neonates 52 paricalcitol 52 PEGASYS ® 52 AZT zidovudine Retrovir 52 NPH insulin 52 hypophosphatemia 52 #mg dosing 52 INVEGA ® 52 oral ibandronate 52 NATRECOR ® 52 indinavir 52 interferon alfa 52 #mg #mg [001] 52 RLAI 52 adalimumab 52 ciprofloxacin hydrochloride 52 ≥ 52 doxazosin 52 steroid dexamethasone 52 intradermal injection 52 emtricitabine tenofovir 52 administered intravenously 52 oxymorphone ER 52 tacrolimus ointment 52 undetectable HBV DNA 52 mm3 52 monotherapy 52 p = .# [002] 52 insulin aspart 52 trastuzumab Herceptin ® 52 carboplatin AUC 6 52 ALVESCO 52 undetectable viral 52 PEGylated Fab fragment 52 Moli# 52 lanthanum carbonate 52 log# reduction 52 CONCERTA 52 Folfox 52 Bezielle 52 fluticasone propionate 52 nitazoxanide 52 AZILECT R 52 indacaterol 52 Lipitor #mg 52 CK # administered 52 dopamine receptor agonist 52 antibody titer 52 Vincristine 52 tolterodine 52 premixed insulin 52 ritonavir boosted lopinavir 52 Isentress raltegravir 52 pouchitis 52 VIRAMUNE 52 adalimumab etanercept 52 ADHD stimulant 52 irbesartan 52 factor TNF 52 mitomycin 52 lopinavir ritonavir Kaletra 52 CANCIDAS 52 mmol kg 52 intravenous infusions 52 citalopram hydrobromide 52 metastatic GIST 52 peak plasma concentrations 52 p ≤ 52 limiting toxicity DLT 52 IFN alfa 52 mesalamine granules 52 intravenous tissue plasminogen 52 methotrexate therapy 52 VIRAMUNE XR 52 transaminase elevations 52 PEGINTRON TM 52 thrombocytopenic patients 52 urocortin 2 52 PEG Intron 52 antiangiogenic therapy 52 QT intervals 52 demonstrated antitumor activity 52 GEMZAR 52 GnRH antagonist 52 pmol liter 52 iobenguane 52 virologic suppression 51 sulfonylurea metformin 51 intramuscular injections 51 antiarrhythmic drugs 51 lanreotide 51 log# copies mL 51 -#.# log# 51 Panzem R NCD 51 Byetta exenatide 51 orally inhaled 51 placebo p = 51 rimonabant #mg 51 mCi m 2 51 Darunavir 51 Lantus R 51 EFFEXOR XR 51 ug dose 51 paclitaxel Taxol 51 androgen ablation 51 cyclophosphamide Cytoxan 51 QVA# 51 clinically meaningful reductions 51 9mg 51 sufentanil 51 glulisine 51 5 Fluorouracil 51 antibiotic prophylaxis 51 lopinavir ritonavir 51 Fingolimod 51 imatinib Gleevec ® 51 histrelin 51 severe hypersensitivity reactions 51 nucleoside analog 51 cholestyramine 51 metered dose inhaler MDI 51 neutrophil counts 51 aplindore 51 recurrent glioblastoma multiforme 51 darbepoetin alfa 51 DOXIL 51 pentoxifylline 51 oral ribavirin 51 pretreatment baseline 51 uL 51 randomized #:#:# 51 docetaxel Taxotere ® 51 radiotherapy RT 51 pegfilgrastim 51 intranasally administered 51 ciclosporin 51 long acting muscarinic 51 zolmitriptan 51 dose escalation phase 51 Inhalation Powder 51 androgen suppression 51 ceftriaxone 51 LCP Tacro TM 51 lymphocytosis 51 pharmacokinetic PK study 51 teriflunomide 51 taxotere 51 Noxafil 51 3TC lamivudine Epivir 51 intramuscular dose 51 MULTAQ 51 KAPIDEX 51 cisplatin chemotherapy 51 dose cohorts 51 inactive placebo 51 plus dexamethasone 51 intratumoral 51 inhalation powder 51 evaluable 51 Twinrix 51 urinary sodium excretion 51 pegylated interferon alpha 2a 51 pharmacologically active isomer 51 MIRAPEX ER 51 CAELYX 51 achieved PASI 51 ug mL 51 headache nasopharyngitis 51 Orally administered 51 oral prednisolone 51 mIU mL 51 liposome formulation 51 dihydrochloride 51 telaprevir dosing 51 MCyR 51 chemoradiotherapy 51 adefovir treated 51 ARIKACE 51 mg kg ip 51 fluticasone 51 #mg dose [003] 51 pooled comparator 51 intra articular injection 51 carbidopa 51 alanine aminotransferase 51 recurrent VTE 51 posttreatment 51 nM 51 anthracycline taxane 51 galiximab 51 nebulization 51 randomized #:# 51 induce remission 51 Copegus ® ribavirin 51 decitabine 51 FOLFOX 51 mitoxantrone chemotherapy 51 glargine 51 clevidipine 51 EDARBI 51 + PH# 51 5-FU/LV 51 #.#mg/kg [001] 51 Protease inhibitor 51 mu g 51 Decitabine 51 dose regimen 51 anthracycline chemotherapy 51 aspartate aminotransferase AST 51 paclitaxel poliglumex 51 tranylcypromine 51 glucuronide 51 azacitidine 51 μSv 51 HBeAg positive 51 dosing cohort 51 PREMARIN Vaginal Cream 51 mg subcutaneous 51 nitrofurantoin 51 glatiramer acetate 51 NeoRecormon 51 Helicobacter pylori eradication 51 ABC/3TC 51 Topotecan 51 laxation 51 antidiabetic medications 51 premedication 51 4mg 51 APTIVUS 51 Prulifloxacin 51 TMP SMX 51 thyroid hormone replacement 51 cidofovir 51 VNP#M 51 pharmacodynamics PD 51 mapatumumab 51 streptozotocin 51 #I TM# 51 achieved statistical significance 51 sUA 51 insulin glargine rDNA origin 51 alfa 2b 51 ALGRX 51 uric acid lowering 51 immunomodulatory therapy 51 systemic hypotension 51 â ‰ ¥ 51 sUA levels 51 aspirin heparin 51 beclomethasone dipropionate 51 Laquinimod 51 SGPT 51 -#.# log# copies mL 51 bupivacaine 51 unboosted 51 methacholine 51 hematologic toxicity 51 pg ml 51 Navelbine ® 51 postmenopausal osteoporotic women 51 prazosin 51 golimumab CNTO 51 pyridostigmine 51 interquartile range 51 lacosamide 51 APRISO 51 gemcitabine cisplatin 51 Intravitreal 51 HBeAg negative patients 51 plus prednisone prednisolone 51 REYATAZ r 51 mercaptopurine 51 FOLPI regimen 51 Adefovir 51 zidovudine lamivudine 51 peginterferon 51 REVLIMID ® 51 virologically suppressed 51 Viread Emtriva 51 evaluable subjects 51 budesonide 51 corticosteroid dexamethasone 51 TOVIAZ 51 Myelosuppression 51 agonist LABA 51 etoposide 51 tolerated dose MTD 51 TNF Tumor Necrosis Factor 51 cisplatin vinorelbine 51 overt nephropathy 51 milliliters mL 51 Rifampin 51 mIU ml 51 hypofractionated 51 VAPRISOL 51 Fludara 51 indapamide 51 MIRCERA 51 clomipramine 51 fludarabine cyclophosphamide 51 anakinra 51 unfractionated heparin 51 n = 51 SCIg 50 Secondary endpoints 50 pioglitazone HCl 50 FRAGMIN 50 seroprotection 50 recurrent genital herpes 50 leucopenia 50 daily Infergen 50 miconazole 50 serum phosphorus levels 50 rhIGF-I/rhIGFBP-3 50 stavudine d4T 50 taxane chemotherapy 50 Decadron 50 ZOMIG 50 atorvastatin #mg 50 receiving prophylactic anticoagulation 50 pegylated interferon 50 mcg ml 50 primary hypercholesterolemia 50 serum magnesium 50 reactogenicity 50 alanine aminotransferase ALT 50 plus OBT 50 GLP1 agonist 50 ZOLINZA 50 % CI #.#-#.# [007] 50 dexamethasone 50 octreotide 50 plus gemcitabine 50 virological failure 50 CIMZIA TM certolizumab pegol 50 titrated 50 prednisone prednisolone 50 endoscopic remission 50 cyclophosphamide 50 Apidra ® 50 plasma glucose 50 busulfan 50 hypokalemia 50 octreotide acetate 50 benazepril 50 nucleotide analogue 50 Peginterferon alfa 2b 50 deferasirox 50 S/GSK# 50 fluorouracil 50 Apidra R 50 oral amoxicillin 50 angiotensin converting enzyme inhibitor 50 aliskiren amlodipine 50 oral renin inhibitor 50 placebo PBO 50 mEq L 50 Forodesine HCl 50 catheter occlusion 50 oxycodone CR 50 remission induction 50 DEB# 50 alteplase 50 unconjugated 50 surgical debulking 50 Eligen R B# 50 nonmyeloablative 50 rocuronium 50 cyclophosphamide doxorubicin vincristine 50 HCV RESPOND 2 50 RGT arm 50 intravesical 50 normothermic 50 unresectable HCC 50 paclitaxel cisplatin 50 IOP lowering 50 conventional DMARDs 50 test OGTT 50 dosed 50 RAPAMUNE 50 PaO 2 50 HCTZ 50 pimecrolimus 50 amoxicillin clavulanic acid 50 pegaptanib 50 paclitaxel chemotherapy 50 enfuvirtide 50 osmolality 50 dobutamine 50 #-#,# mg 50 bolus doses 50 intramuscular 50 trospium chloride 50 pmol L 50 micafungin 50 dose escalation 50 certolizumab pegol 50 immunosuppressive regimen 50 timolol 50 debulking surgery 50 mg ml 50 LATUDA 50 H2RAs 50 BYETTA exenatide injection 50 myelodysplastic myeloproliferative diseases 50 azacytidine 50 metformin sulphonylurea 50 ULORIC 50 Tarceva TM 50 tapentadol ER 50 HERCEPTIN 50 recombinant tissue plasminogen 50 Gabapentin GR 50 High Dose quadruples 50 daunorubicin 50 BEACOPP 50 TURBT 50 Adalimumab 50 % Confidence Interval 50 dose escalations 50 liposomal formulation 50 G CSF 50 omalizumab Xolair 50 CIMZIA ™ 50 abacavir Ziagen 50 Prosaptide 50 oral corticosteroids 50 etanercept 50 transaminase 50 plasma HCV RNA 50 μl 50 quetiapine XR 50 glatiramer acetate GA 50 P = .# 50 mometasone